Gene: TPD52
Official Full Name: tumor protein D52provided by HGNC
Gene Summary: Enables calcium ion binding activity and protein homodimerization activity. Involved in B cell differentiation. Located in endoplasmic reticulum and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34950 | TPD52 Knockout cell line (HeLa) | Human | TPD52 | 1:3~1:6 | Negative | Online Inquiry |
KO34951 | TPD52 Knockout cell line (HCT 116) | Human | TPD52 | 1:2~1:4 | Negative | Online Inquiry |
KO34952 | TPD52 Knockout cell line (HEK293) | Human | TPD52 | 1:3~1:6 | Negative | Online Inquiry |
KO34953 | TPD52 Knockout cell line (A549) | Human | TPD52 | 1:3~1:4 | Negative | Online Inquiry |
TPD52 Gene Knockout Cell Lines are specialized cell lines that have undergone targeted genetic modification to knock out the TPD52 gene, which is implicated in several cellular processes including proliferation, differentiation, and tumorigenesis. The knockout of this gene allows for detailed exploration of its functional roles and the pathways it influences, providing researchers with a powerful tool for studying various biological phenomena, particularly in cancer research.
The key function of TPD52 gene knockout cell lines lies in their ability to elucidate the gene's contributions to cellular behavior. By removing TPD52, researchers can investigate alterations in molecular signaling, changes in cell cycle dynamics, and the complex interactions within cellular ecosystems that may occur as a direct consequence of the gene's absence. The operability of these cell lines enables experiments such as gene expression analysis, protein localization studies, and functional assays that can reveal novel insights into oncogenic processes and the development of therapeutic targets.
The scientific importance of TPD52 gene knockout cell lines extends beyond basic research; they offer significant applications in preclinical settings, aiding in the identification of drug targets and testing the efficacy of therapeutic compounds. By employing these knockout models, researchers can model human diseases more accurately, paving the way for advancements in personalized medicine.
Compared to other genetic modification tools such as CRISPR/Cas9, TPD52 gene knockout cell lines provide a ready-to-use platform that eliminates the need for lengthy customization and validation processes, thus accelerating the timeline from conception to experimentation. Additionally, these cell lines are validated for stability and consistency in various laboratory settings, ensuring reliable reproducibility of results.
For researchers and clinicians alike, TPD52 Gene Knockout Cell Lines represent a valuable asset in the pursuit of understanding the intricacies of gene function and its implications in health and disease. Their ease of use, coupled with their potential to uncover novel biological insights, makes them a go-to tool in the toolkit of modern molecular biology.
Our company specializes in the development of advanced biological models and reagents, enabling the research community to accelerate discoveries that impact health and medicine. With a commitment to quality and innovation, we provide products that empower researchers to push the boundaries of what's possible in the study of genetic interventions and their effects on cellular systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.